EURAND N.V. EURX (NASDAQ)

$ 12.35
13:46
Sponsored by
Click here!
Change: +1.18 (+10.56%)
Volume: 141,718

Avg. Volume: 139091
P/E Ratio: 0
EPS (Annual): -0.40
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 44,380
Institutional Shareholders: 15.80%
Last: 12.35
Change: +1.18 (+10.56%)
Prev. Close: 11.17
Open: 11.59
Day's Range: 11.59 - 12.56
52wk Range: 9.86 - 19.60
Market Value: 468,490
Beta:
12-month EPS Change: 0.00%
Total Return Last 12 Months: -34.18%
Total Return Last 3 Years: -25.16%
Total Return Last 5 Years: -27.66%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on EURX
Alert me Subscribe

Eurand expects delay in lead drug application

(NEW YORK)Drug developer Eurand NV said Tuesday it expects the Food and Drug Administration to take an additional quarter to make a decision on its lead drug candidate because of a raw mater...READ MORE
Sep 30, 2008 10:40AM
Keywords: EURX
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

PFIZER INC -29.10 16.68
JOHNSON AND JOH -4.00 62.68
MERCK CO INC -46.10 29.42
BRISTOL MYERS S -31.60 19.00
SCHERING PLOUGH -52.40 14.82